PetMed Express misses Q4 earnings and revenue estimates, stock falls

it.investing.com (Italian)

PetMed Express reported a Q4 loss per share of -$0.19, missing analyst estimates. The company's Q4 revenue was $42.8 million, down 15.6% year-over-year, primarily due to declining prescription drug sales. PetMed Express also announced it received and rejected two unsolicited acquisition offers in December 2025.


With a significance score of 1, this news ranks in the top 68% of today's 33725 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


PetMed Express misses Q4 earnings and revenue estimates, stock falls | News Minimalist